Cell Therapy Technologies Market Size, Share, Growth Analysis, By Technology(Viral Vector Technology, Genome Editing Technology, Somatic Cell Technology, Cell Immortalization Technology), By Use(Clinical Use), By Cell(Stem Cell Therapies, BM, Blood, & Umbilical Cord-derived Stem Cells), By Therapy(Allogenic Therapies, Autologous Therapies), By Product(Consumables, Equipment, Systems, and Software), By Therapeutic Area(Oncology, Musculoskeletal Diseases), By Region - Industry Forecast 2024-2031

Global Cell Therapy Technologies Market size was valued at USD 9.73 Billion in 2022 and is poised to grow from USD 2.12 Billion in 2023 to USD 55.32 Billion by 2031, growing at a CAGR of 12.14% in the forecast period (2024-2031).

Increase in funding for cell therapy clinical research, acceptance of practical guidelines for cell therapy production, product success is some of the key factors influencing the growth of the number of companies in the market. Cell therapy by quality research and research projects are providing to enhance the development of therapeutic cells. This has directly contributed to the growth of market share over the years. The increase in the number of clinical trials can be attributed to the existence of private and government funding agencies that continue to grant approvals to support transactions in clinical trials. Most subsequent projects in Europe are funded by EU grants. For example, in July 2022, Achilles Therapeutics announced that it had received a Horizon Europe award for the US. $4.2 million, the largest budget for research and innovation in the European Union. This money was allocated to advance personalized medicine.

Cell therapy technologies have attracted increasing attention in recent years for their potential to revolutionize the treatment of various diseases. New trends and technological advancements are driving the market for cell therapy technologies. Advances in cell therapy techniques, gene editing technologies (e.g., CRISPR/Cas9), and biomaterials are contributing to the creation of effective and scalable cell therapies. The combination of automation and robotics simplifies manufacturing processes, reduces costs and improves the reproducibility and quality of cell therapy products. Regulatory approvals significantly influence the market dynamics of cell therapy technologies.